BackRenovoRx Overview

RenovoRx Current Cash

Track RenovoRx's current cash ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$12.36M
↓ 15.22% YoYΔ $-2.22M vs prior year quarter

Peer average / median

Loading

RenovoRx Current Cash History

Loading

RenovoRx vs. peers: Current Cash Comparison

Loading

RenovoRx Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

RenovoRx (RNXT) FAQ

RenovoRx (RNXT) currently reports a current cash of $12M as of March 2026. That compares with $15M in the prior-year period — down 15.2% year over year. Use the charts on this page to explore RenovoRx's current cash history and peer comparisons.

RenovoRx's current cash decreased from $15M to $12M — a 15.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

RenovoRx reported $12M in current cash as of March 2026. That compares with $15M in the prior-year period — down 15.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for RenovoRx, and consider following RNXT for alerts when major investors trade the stock.